[Investigating erythrocyte hemolysis assay use for proinflammatory potential prediction of silica particles].

Q4 Medicine
Takaki Amamoto, Tatsushi Toyooka, Maromu Yamada, Yukie Yanagiba, Rui-Sheng Wang, Shigeki Koda
{"title":"[Investigating erythrocyte hemolysis assay use for proinflammatory potential prediction of silica particles].","authors":"Takaki Amamoto,&nbsp;Tatsushi Toyooka,&nbsp;Maromu Yamada,&nbsp;Yukie Yanagiba,&nbsp;Rui-Sheng Wang,&nbsp;Shigeki Koda","doi":"10.1539/sangyoeisei.2021-043-B","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Crystalline silica, which is a causative agent of silicosis (an occupational disease), is manufactured in a variety of products (particles) with different particle characteristics, such as size and surface properties. In Japan, the products are currently uniformly controlled as crystalline silica, which is a substance subject to labeling and notification requirements. However, since the toxicity of silica particles reportedly varies depending on its characteristics, businesses are encouraged to conduct appropriate risk assessments for each product to prevent silicosis. Recently, silica particles have been reported to induce lysosomal membrane damage, leading to the activation of proinflammatory factors. An indirect method to evaluate lysosomal membrane damage known as the erythrocyte hemolysis assay, in which the erythrocyte membrane is assumed to be the lysosomal membrane, was performed. This study aimed to examine the possibility of constructing a screening system for proinflammatory potential prediction of silica particles based on their erythrocyte hemolytic activity.</p><p><strong>Methods: </strong>Hemolysis assays were performed on the silica particles with different sizes, crystallinity, and surface functional groups using the erythrocytes from a healthy volunteer. Additionally, the hemolytic activity of other element particles was compared with that of the silica particles, and 27 types of commercially available crystalline silica particle products underwent screening trials.</p><p><strong>Results: </strong>The hemolytic activity of silica particles was higher in crystalline than that in amorphous and increased with the decreasing size. The hemolytic reaction was particular to silica particles and rarely occurred in particles of other elements. Moreover, the hemolytic activity was significantly suppressed if the silica particles surface was modified with metal ions (Fe<sup>3+</sup>, Al<sup>3+</sup>). The hemolytic activities of the crystalline silica products used industrially significantly differed.</p><p><strong>Conclusions: </strong>This study revealed that particle properties, such as size, crystallinity, and surface functional groups, affect the hemolytic activity of silica particles. Particularly, the surface functional groups (silanol groups) that are unique to silica particles were considered to be strongly involved in hemolytic activities. Since grading the commercially available crystalline silica particle products based on the hemolytic rate was possible, hemolytic activity was suggested to be an evaluation index for predicting the proinflammatory potential of silica particles.</p>","PeriodicalId":40039,"journal":{"name":"Sangyo eiseigaku zasshi = Journal of occupational health","volume":"65 3","pages":"125-133"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sangyo eiseigaku zasshi = Journal of occupational health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1539/sangyoeisei.2021-043-B","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Crystalline silica, which is a causative agent of silicosis (an occupational disease), is manufactured in a variety of products (particles) with different particle characteristics, such as size and surface properties. In Japan, the products are currently uniformly controlled as crystalline silica, which is a substance subject to labeling and notification requirements. However, since the toxicity of silica particles reportedly varies depending on its characteristics, businesses are encouraged to conduct appropriate risk assessments for each product to prevent silicosis. Recently, silica particles have been reported to induce lysosomal membrane damage, leading to the activation of proinflammatory factors. An indirect method to evaluate lysosomal membrane damage known as the erythrocyte hemolysis assay, in which the erythrocyte membrane is assumed to be the lysosomal membrane, was performed. This study aimed to examine the possibility of constructing a screening system for proinflammatory potential prediction of silica particles based on their erythrocyte hemolytic activity.

Methods: Hemolysis assays were performed on the silica particles with different sizes, crystallinity, and surface functional groups using the erythrocytes from a healthy volunteer. Additionally, the hemolytic activity of other element particles was compared with that of the silica particles, and 27 types of commercially available crystalline silica particle products underwent screening trials.

Results: The hemolytic activity of silica particles was higher in crystalline than that in amorphous and increased with the decreasing size. The hemolytic reaction was particular to silica particles and rarely occurred in particles of other elements. Moreover, the hemolytic activity was significantly suppressed if the silica particles surface was modified with metal ions (Fe3+, Al3+). The hemolytic activities of the crystalline silica products used industrially significantly differed.

Conclusions: This study revealed that particle properties, such as size, crystallinity, and surface functional groups, affect the hemolytic activity of silica particles. Particularly, the surface functional groups (silanol groups) that are unique to silica particles were considered to be strongly involved in hemolytic activities. Since grading the commercially available crystalline silica particle products based on the hemolytic rate was possible, hemolytic activity was suggested to be an evaluation index for predicting the proinflammatory potential of silica particles.

[研究红细胞溶血试验用于预测二氧化硅颗粒的促炎潜力]。
目的:晶体二氧化硅是矽肺病(一种职业病)的病原体,它以各种具有不同颗粒特性(如大小和表面特性)的产品(颗粒)生产。在日本,这些产品目前被统一控制为结晶二氧化硅,这是一种受标签和通知要求约束的物质。然而,由于二氧化硅颗粒的毒性据报道因其特性而异,因此鼓励企业对每种产品进行适当的风险评估,以预防矽肺病。最近,二氧化硅颗粒已被报道诱导溶酶体膜损伤,导致促炎因子的激活。一种评估溶酶体膜损伤的间接方法被称为红细胞溶血试验,其中红细胞膜被认为是溶酶体膜。本研究旨在探讨构建基于二氧化硅颗粒红细胞溶血活性的促炎潜能预测筛选系统的可能性。方法:采用健康志愿者红细胞,对不同粒径、结晶度和表面官能团的二氧化硅颗粒进行溶血实验。此外,还比较了其他元素颗粒与二氧化硅颗粒的溶血活性,并对27种市售结晶二氧化硅颗粒产品进行了筛选试验。结果:结晶二氧化硅颗粒溶血活性高于非晶二氧化硅颗粒,且溶血活性随粒径的减小而增大。溶血反应只发生在二氧化硅颗粒中,很少发生在其他元素的颗粒中。此外,如果用金属离子(Fe3+, Al3+)修饰二氧化硅颗粒表面,则可以显著抑制其溶血活性。工业上使用的结晶二氧化硅产品的溶血活性显著不同。结论:本研究揭示了颗粒的性质,如大小、结晶度和表面官能团,会影响二氧化硅颗粒的溶血活性。特别是,二氧化硅颗粒特有的表面官能团(硅醇基团)被认为与溶血活性密切相关。由于可以根据溶血率对市售结晶二氧化硅颗粒产品进行分级,因此建议将溶血活性作为预测二氧化硅颗粒促炎潜力的评价指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.30
自引率
0.00%
发文量
40
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信